PE13197A1 - Venlafaxina en el tratamiento de amenorrea hipotalamica en mujeres no deprimidas - Google Patents

Venlafaxina en el tratamiento de amenorrea hipotalamica en mujeres no deprimidas

Info

Publication number
PE13197A1
PE13197A1 PE1996000060A PE00006096A PE13197A1 PE 13197 A1 PE13197 A1 PE 13197A1 PE 1996000060 A PE1996000060 A PE 1996000060A PE 00006096 A PE00006096 A PE 00006096A PE 13197 A1 PE13197 A1 PE 13197A1
Authority
PE
Peru
Prior art keywords
venlafaxine
treatment
hypothalamic amenorrhea
depressed
depressed women
Prior art date
Application number
PE1996000060A
Other languages
English (en)
Inventor
Gertrude V Upton
Albert T Derivan
Richard L Rudolph
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23502899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE13197(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of PE13197A1 publication Critical patent/PE13197A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN METODO PARA TRATAR LA AMENORREA HIPOTALAMICA EN UN MAMIFERO FEMENINO NO DEPRIMIDO, QUE COMPRENDE UNA DOSIS EFECTIVA DEL COMPUESTO DE FORMULA (I), DONDE: A ES CICLOALCANOL DE (C4-C8), CON HASTA UNA INSATURACION OPCIONAL; R1 Y R7 SON H o R2; R2 ES ALQUILO(C1-C6); R5 Y R6 ES INDEPENDIENTEMENTE H, OH, R2 O ALCOXI(C1-C6), ENTRE OTROS; n ES 0, 1, 2, 3 O 4. ADEMAS REFIERE QUE UNA DOSIS EFECTIVA VARIA DE 1 A 375 mg DEL COMPUESTO (I) DIARIA
PE1996000060A 1995-01-30 1996-01-29 Venlafaxina en el tratamiento de amenorrea hipotalamica en mujeres no deprimidas PE13197A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/380,903 US5506270A (en) 1995-01-30 1995-01-30 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women

Publications (1)

Publication Number Publication Date
PE13197A1 true PE13197A1 (es) 1997-04-22

Family

ID=23502899

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000060A PE13197A1 (es) 1995-01-30 1996-01-29 Venlafaxina en el tratamiento de amenorrea hipotalamica en mujeres no deprimidas

Country Status (17)

Country Link
US (1) US5506270A (es)
EP (1) EP0723779A1 (es)
JP (1) JPH08231387A (es)
KR (1) KR960028906A (es)
CN (1) CN1137894A (es)
AR (1) AR001074A1 (es)
AU (1) AU703529B2 (es)
CA (1) CA2167999A1 (es)
CZ (1) CZ22996A3 (es)
FI (1) FI956339A (es)
HU (1) HUT75095A (es)
IL (1) IL116935A0 (es)
NO (1) NO955356L (es)
NZ (1) NZ280744A (es)
PE (1) PE13197A1 (es)
SK (1) SK11596A3 (es)
ZA (1) ZA9511038B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US20060073201A1 (en) * 1996-03-25 2006-04-06 Wyeth Extended release formulation
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
CA2368083A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Derivatives of venlafaxine and methods of preparing and using the same
US20020022662A1 (en) * 1999-06-15 2002-02-21 American Home Products Corporation Enantiomers of O-desmethyl venlafaxine
US20020035158A1 (en) * 1999-06-15 2002-03-21 American Home Products Corporation Enantiomers of N-desmethyl venlafaxine
US6348494B1 (en) * 2000-11-21 2002-02-19 American Home Products Corporation Ethers of o-desmethyl venlafaxine
US7291646B2 (en) * 1999-11-24 2007-11-06 Wyeth Ethers of O-desmethyl venlafaxine
US6572890B2 (en) * 2000-01-13 2003-06-03 Osmotica Corp. Osmotic device containing venlafaxine and an anti-psychotic agent
FR2807753B1 (fr) * 2000-04-13 2002-06-07 Adir Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK1360169T3 (da) † 2001-02-12 2007-11-26 Wyeth Corp Succinatsalt af O-desmethyl-venlafaxin
EP1451145A1 (en) * 2001-12-05 2004-09-01 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
AU2003219117A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Extended release venlafaxine formulations
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
EP1523981A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release formulations of venlafaxine
EP1523979A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release pharmaceutical dosage form
CN101257898A (zh) * 2005-07-06 2008-09-03 塞普拉科公司 艾司佐匹克隆与o-去甲基文拉法辛的组合以及治疗绝经期和心境障碍、焦虑症和认知障碍的方法
EP1957470A1 (en) * 2005-12-05 2008-08-20 Wyeth Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
KR100965527B1 (ko) * 2008-05-08 2010-06-23 제일약품주식회사 신규(4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시)포스페이트 또는 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계질환 예방 및 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110438A (en) * 1977-03-21 1978-08-29 American Home Products Corporation Method of treating depression
US4291028A (en) * 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
HUT75095A (en) 1997-04-28
NZ280744A (en) 2000-11-24
IL116935A0 (en) 1996-05-14
CN1137894A (zh) 1996-12-18
ZA9511038B (en) 1997-06-30
FI956339A (fi) 1996-07-31
CA2167999A1 (en) 1996-07-31
AU4075295A (en) 1996-08-08
AR001074A1 (es) 1997-09-24
NO955356L (no) 1996-07-31
SK11596A3 (en) 1997-05-07
AU703529B2 (en) 1999-03-25
KR960028906A (ko) 1996-08-17
EP0723779A1 (en) 1996-07-31
FI956339A0 (fi) 1995-12-29
JPH08231387A (ja) 1996-09-10
CZ22996A3 (en) 1996-09-11
NO955356D0 (no) 1995-12-29
US5506270A (en) 1996-04-09
HU9503922D0 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
PE13197A1 (es) Venlafaxina en el tratamiento de amenorrea hipotalamica en mujeres no deprimidas
MX9304435A (es) Compuesto y composicion farmaceutica para el tratamiento y la profilaxis de la obesidad o para el tratamiento de la diabetes del tipo ii.
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
ES2091467T3 (es) Composicion y metodo para mejorar el bronceado solar.
ES2165990T3 (es) Thip para el tratamiento de trastornos del sueño.
CO4290359A1 (es) Metodo para tratar la alopecia androgenica con inhibidores 5-alfa-reductasa
ES2159560T3 (es) Inhibicion del crecimiento del pelo.
MY106938A (en) Method of treating premature ejaculation using sertraline
ES2153851T3 (es) Tratamiento de la atrofia de la piel y de la vagina.
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
DE69332713D1 (de) Verwendung von Histamine-2 Agonisten zur Behandlung sexueller Funktionsstörungen
ES2143131T3 (es) Proceso para eliminacion de colorantes.
BG106461A (en) Methods and use of rapid onset of reactive serotonin inhibitors for treating sexual dysfunction
ES2078890T3 (es) Amino esteroides en c20 a c26.
ES2051652A6 (es) Procedimiento para la preparacion de compuestos inhibidores de fosfolipasa a2
RU94045277A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования расстройств цнс у женщин в постменопаузе
ES2144017T3 (es) Composicion para el tratamiento externo de la piel.
CA2218028A1 (en) Brain edema inhibitor
NO962655L (no) Deutrerte virkestoffer i transdermal applikasjon
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
BG105142A (en) Oxazolidinones to treat eye infections
MXPA03005922A (es) Metodo para tratar glaucoma ib.
KR910016342A (ko) 항원 용액을 위한 보조제로서의 아연, 칼슘 하이드록 사이드, 렉시틴 및 pao의 용도, 및 이러한 유형의 보조제로 처리된 항원 용액
FI961054A0 (fi) Menetelmä 9-(2-hydroksi)etoksimetyyliguaniinin valmistamiseksi
ATE435023T1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen

Legal Events

Date Code Title Description
FC Refusal